Medicine
Interplay Between Gut Permeability and Autoimmune Hepatitis
Quick fact
In autoimmune hepatitis, patients often show elevated markers of intestinal permeability, such as serum zonulin and lipopolysaccharide-binding protein, suggesting that a compromised gut barrier is a hidden contributor to liver inflammation.
Why this is interesting
Your gut lining is over three hundred square meters—a huge gateway. Could a 'leaky' gate be what sparks your immune system to attack your own liver?
Read the full explanation
Understanding Interplay Between Gut Permeability and Autoimmune Hepatitis
Imagine your intestines as a long, selectively porous fence. Their main job is to let digested nutrients in while keeping harmful microbes and toxins out. That fence is the mucosal barrier, formed by a single layer of cells linked by 'tight junctions'—proteins that zipper the cells together. When those junctions loosen, the fence becomes leaky: a 'leaky gut.' Large molecules, bacterial fragments, and even whole bacteria can then slip between the cells and enter the bloodstream. The liver, which is the first port of call for blood draining the gut (via the portal vein), becomes a kind of grand central station for these unwanted travelers. In autoimmune hepatitis (AIH), the immune system mistakenly targets liver cells. This card shows how a leaky gut could be one of the sparks that ignites that attack, and how it fuels the fire once it starts.
A deeper explanation
The mechanism starts at the tight junctions. Proteins like claudins and occludins, regulated by zonulin, control the paracellular space. Stress, diet, infections, or dysbiosis can release zonulin, loosening those junctions and increasing intestinal permeability. When bacterial products, such as lipopolysaccharide (LPS), leak into the portal circulation, they reach the liver. There, they engage pattern recognition receptors on immune cells—like Kupffer cells and dendritic cells—creating a pro-inflammatory environment. This inflammatory milieu upregulates adhesion molecules and promotes activation of T cells. In a genetically susceptible person, these T cells may cross-react with liver self-antigens due to molecular mimicry—bacterial peptides resembling liver proteins. Activated T cells then infiltrate the liver lobule, causing interface hepatitis, elevated transaminases, and fibrosis. Importantly, the inflammation itself can further damage tight junctions, creating a vicious cycle: leaky gut worsens liver inflammation, and liver inflammation increases gut permeability. This bidirectional 'gut–liver axis' is why targeting gut permeability is being explored as an adjunctive therapy in AIH.